SIC
AURA icon

SJS Investment Consulting’s Aura Biosciences AURA Stock Holding History

SJS Investment Consulting’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$923 Buy
130
+128
+6,400% +$916 ﹤0.01% 2057
2026
Q1 		$14 Buy
+2
New +$11 ﹤0.01% 2400

Other funds holding AURA

Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

SJS Investment Consulting's AURA Position: Q2 2026 in Review

SJS Investment Consulting increased its Aura Biosciences (AURA) stake by 6,400% in Q2 2026, buying an estimated $916 and bringing the position to 130 shares worth $923. The position accounts for ﹤0.01% of the portfolio, ranked #2057.

SJS Investment Consulting first reported a position in AURA in Q1 2026 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • SJS Investment Consulting held 130 shares of Aura Biosciences worth $923 as of Q2 2026.
  • SJS Investment Consulting bought 128 Aura Biosciences shares in Q2 2026, an estimated $916.
  • Aura Biosciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2057 holding.
  • SJS Investment Consulting first reported a position in Aura Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.